TARGETING THE ATM-MPG AXIS OVERCOMES ALKYLATING AGENT RESISTANCE IN PEDIATRIC GLIOBLASTOMA

被引：0
|
作者：
Hawkins, Cynthia [1 ]
Burrell, Kelly [1 ]
Chornenkyy, Yevgen [2 ]
Remke, Mark [1 ]
Golbourn, Brian [1 ]
Buczkowicz, Pawel [2 ]
Barzczyk, Mark [2 ]
Taylor, Michael [1 ]
Rutka, James [1 ]
Dirks, Peter [1 ]
Zadeh, Gelareh [3 ]
Agnihotri, Sameer [1 ]
机构：
[1] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ Hlth Network, Toronto, ON, Canada
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
HG-057
引用
收藏
页码：54 / 54
页数：1
相关论文
共 36 条
  • [1] Targeting DNA Damage Response Pathways to Overcome Alkylating Agent Resistance in Pediatric Glioblastoma
    Hawkins, Cynthia
    Burrell, Kelly
    Fernandez, Nestor
    Clarke, Ian
    Barszczyk, Mark
    Sabha, Nesrin
    Sobol, Robert
    Dirks, Peter
    Jones, Chris
    Zadeh, Gelareh
    Agnihotri, Sameer
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2013, 72 (06): : 573 - 574
  • [2] TARGETING DNA DAMAGE RESPONSE PATHWAYS TO OVERCOME ALKYLATING AGENT RESISTANCE IN PEDIATRIC GLIOBLASTOMA
    Agnihotri, Sameer
    Burrell, Kelly
    Fernandez, Nestor
    Golbourn, Brian
    Clarke, Ian
    Barszczyk, Mark
    Sabha, Nesrin
    Dirks, Peter
    Jones, Chris
    Rutka, James
    Zadeh, Gelareh
    Hawkins, Cynthia
    NEURO-ONCOLOGY, 2013, 15 : 27 - 28
  • [3] Alkylating agent resistance in pediatric oncology
    Yule, SM
    Kearns, PR
    Hall, AG
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1997, 4 (06): : 613 - 628
  • [4] AN ATM-APNG DNA REPAIR AXIS CONFERS AN ALKYLATING AGENT RESISTANCE PHENOTYPE IN ADULT AND PEDIATRIC HIGH-GRADE GLIOMA
    Agnihotri, Sameer
    Ternamian, Christian
    Jones, Chris
    Zadeh, Gelareh
    Rutka, James
    Hawkins, Cynthia
    NEURO-ONCOLOGY, 2012, 14 : 63 - 63
  • [5] Targeting the IRAK1-S100A9 Axis Overcomes Resistance to Paclitaxel in Nasopharyngeal Carcinoma
    Liu, Lizhen
    Liu, Sailan
    Deng, Peng
    Liang, Yujing
    Xiao, Rong
    Tang, Lin-Quan
    Chen, Jinghong
    Chen, Qiu-Yan
    Guan, Peiyong
    Yan, Shu-Mei
    Huang, Xiangliang
    Hong, Jing Han
    Chen, Jianfeng
    Sun, Yichen
    Teh, Bin Tean
    Yu, Qiang
    Mai, Hai-Qiang
    Tan, Jing
    CANCER RESEARCH, 2021, 81 (05) : 1413 - 1425
  • [6] DUAL TARGETING OF IL-6 AND CD40 OVERCOMES GLIOBLASTOMA RESISTANCE TO IMMUNE CHECKPOINT BLOCKADE
    Yang, Fan
    Brem, Steven
    Fan, Yi
    NEURO-ONCOLOGY, 2020, 22 : 107 - 107
  • [7] CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells
    Dinic, Jelena
    Rios-Luci, Carla
    Karpaviciene, Ieva
    Cikotiene, Inga
    Fernandes, Miguel X.
    Pesic, Milica
    Padron, Jose M.
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (03) : 584 - 598
  • [8] CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells
    Jelena Dinić
    Carla Ríos-Luci
    Ieva Karpaviciene
    Inga Cikotiene
    Miguel X. Fernandes
    Milica Pešić
    José M. Padrón
    Investigational New Drugs, 2020, 38 : 584 - 598
  • [9] Resveratrol as an antitumor agent for glioblastoma multiforme: Targeting resistance and promoting apoptotic cell deaths
    Karkon-Shayan, Sepideh
    Aliashrafzadeh, Hasan
    Dianat-Moghadam, Hassan
    Rastegar-Pouyani, Nima
    Majidi, Mohammadreza
    Zarei, Mahdi
    Moradi-Vastegani, Sadegh
    Bahramvand, Yaser
    Babaniamansour, Sepideh
    Jafarzadeh, Emad
    ACTA HISTOCHEMICA, 2023, 125 (06)
  • [10] Targeting ARPC1B Overcomes Immune Checkpoint Inhibitor Resistance in Glioblastoma by Reversing Protumorigenic Macrophage Polarization
    Liu, Tianqi
    Sun, Tao
    Chen, Xin
    Wu, Jianqi
    Sun, Xiaoqian
    Liu, Xing
    Yan, Haixu
    Fu, Qiang
    Fan, Zirong
    Wang, Xiangyu
    Cheng, Peng
    Cheng, Wen
    Wu, Anhua
    CANCER RESEARCH, 2025, 85 (07) : 1236 - 1252
1234